Navigation Links
Conseco Reports First Quarter Results
Date:5/7/2008

rability of our deferred tax asset; (v) changes in accounting principles and the interpretation thereof; (vi) our ability to achieve anticipated expense reductions and levels of operational efficiencies including improvements in claims adjudication and continued automation and rationalization of operating systems; (vii) performance of our investments; (viii) our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition; (ix) the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject; (x) our ability to remediate the material weakness in internal controls over the actuarial reporting process that we identified at year-end 2006 and to maintain effective controls over financial reporting; (xi) our ability to continue to recruit and retain productive agents and distribution partners and customer response to new products, distribution channels and marketing initiatives; (xii) our ability to achieve eventual upgrades of the financial strength ratings of Conseco and our insurance company subsidiaries as well as the potential impact of rating downgrades on our business; (xiii) the risk factors or uncertainties listed from time to time in our filings with the Securities and Exchange Commission; (xiv) regulatory changes or actions, including those relating to regulation of the financial affairs of our insurance companies, such as the payment of dividends to us, regulation of financial services affecting (among other things) bank sales and underwriting of insurance products, regulation of the sale, underwriting and pricing of products, and health care regulation affecting health insurance products; (xv) general economic conditions and other factors, including prevailing interest rate levels, stock and credit market performance and health care inflation, which may affect (among othe
'/>"/>
SOURCE Conseco, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Insurance Department Fines Conseco Under Pennsylvania-Led, Multi-State Agreement
2. Conseco Reaches Settlement of Multistate Market Conduct Examination
3. Conseco Sets Earnings Release Date
4. Bischof Promoted to Vice President, Enterprise Risk Management at Conseco
5. Conseco Reports Fourth Quarter and Year-End Results
6. Conseco Files 10-K and Sets Earnings Release Date
7. Conseco Reports Preliminary Fourth Quarter and Year-End Results
8. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
9. Conseco Files to Formally Extend Due Date for Annual Report on Form 10-K to March 17 and Reschedules Earnings Release and Investor Call
10. Hacker Joins Conseco as Senior Vice President and Treasurer
11. Tongson Joins Conseco as Senior Vice President, Corporate Actuarial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... 2014 The SI Joint Evaluation and ... six muscle energy techniques. Michael P. Reiman PT, DPT, ... examination techniques for the SI Joint. This ... live course presentation with North American Seminars. ... Applying a differential diagnosis approach to a thorough examination ...
(Date:8/30/2014)... The KSF (Kung Fu Sanshou Federation) presents ... November 8th, 2014 at the Mobile Civic Center in ... many notorious and notable fighters for some top international ... , Among these KSF along with the Shaolin ... with the virtues of true indomitable Shaolin spirit, among ...
(Date:8/30/2014)... Spain Saturday 30 August 2014: The first ... patients with acute coronary syndromes (ACS) are published ... position paper was written jointly by the European ... Association (ACCA) and the European Association of Percutaneous ... , Professor Bulent Gorenek (Turkey), chairperson of the ...
(Date:8/30/2014)... 2014: The first recommendations on the use of ... published today in new ESC Guidelines. The guidelines ... V. Konstantinides (Germany/Greece) and Professor Adam Torbicki (Poland). ... and management of acute pulmonary embolism" are published ... on the ESC Website. , Venous thromboembolism (VTE) ...
(Date:8/29/2014)... August 29, 2014 Daily Gossip writes in ... program on the market nowadays. This method promises to teach ... the use of some effective alternative sources for the production ... energy sources are wind and solar power. , The ... easily accessible in an eBook. So, this is an online ...
Breaking Medicine News(10 mins):Health News:North American Seminars Online PT Continuing Education Course, Examination and Treatment of the SI Joint, Receives Continuing Education Approval in NJ, CA, IL, PA, & TX 2Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 2Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 3Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 4Health News:First multidisciplinary recommendations on management of arrhythmias in ACS patients 2Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2Health News:Home Made Energy Review Exposes Simple Method to Access Alternative Energy Sources 2
... reneged on its pledge to provide more flexible working in ... Journal. , Nearly 70% of medical students are women, and ... But despite its pledges in 2000, made in the governments ... the policy commitment made by the pay negotiating body NHS ...
... on why some people suffer from recurrent episodes of ... by a drop in blood pressure, fainting episodes, difficulty ... these individuals, researchers have found mast cells (a type ... a mutated cell surface receptor that disturbs normal processes ...
... New research explains why some ovarian cancer patients ... post-operative treatment. The findings show that the difference between ... the different biological properties of the tumors. Understanding ovarian ... exploration of specific tumor-targeted therapy, such as DNA profiling, ...
... Protection Awareness, NORTH CHICAGO, Ill., Nov. 9 ... ABT ) has donated a "Cool Globes",sculpture from ... the Lake,County Forest Preserves (LCFP) as a permanent display ... The "Cool Globes" program, which Abbott sponsored, featured ...
... 9 NutraCea (OTC Bulletin Board:,NTRZ), a health ... rice bran,(SRB), announced today that it will release ... after the market closes. Management will host ... PM EST,to review NutraCea,s 2007 third quarter financial ...
... 9 The Menninger Clinic, the,international specialty psychiatric ... Mental Health Epicenter -- that include The,Clinic,s new ... research,treatment, training and advocacy., Menninger will be ... Center on South Main Street, near South Post ...
Cached Medicine News:Health News:UK government has reneged on pledge for flexible working in NHS 2Health News:Abnormal immune cells may cause unprovoked anaphylaxis 2Health News:Abnormal immune cells may cause unprovoked anaphylaxis 3Health News:Abbott Donates 'Cool Globe' to Lake County Forest Preserves for Permanent Display at Greenbelt Cultural Center 2Health News:Abbott Donates 'Cool Globe' to Lake County Forest Preserves for Permanent Display at Greenbelt Cultural Center 3Health News:NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14 2Health News:The Menninger Clinic Unveils Plans for Mental Health Epicenter; Exceeds Halfway Point in $125 Million Capital Campaign 2Health News:The Menninger Clinic Unveils Plans for Mental Health Epicenter; Exceeds Halfway Point in $125 Million Capital Campaign 3
(Date:8/29/2014)... SPRING, Md. , Aug. 29, 2014  United ... that the U.S. District Court for the District of ... its favor in the company,s case against Sandoz, Inc. ... Judge Peter Sheridan ruled that U.S. Patent ... Inc., and enjoined Sandoz from marketing its generic product ...
(Date:8/29/2014)... August 29, 2014 According ... Product & Services (Equipment, Reagent, Primer, Probe, Custom ... PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) - ... global Oligonucleotide Synthesis Market is expected to reach ... 2014, growing at a CAGR of 9.8% from ...
(Date:8/29/2014)... , Aug. 29, 2014  Unilife Corporation ("Unilife" or ... today that it intends to release its financial results ... June 30, 2014 after market trading ends on Tuesday, ... a conference call for 4:30 p.m. U.S. EDT on ... 6:30 a.m. AEST), to review the Company,s financial results, commercial ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
... Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading ... release its unaudited financial results for the first quarter ended ...  The Company will host a conference call on Tuesday, May ... 8:00 p.m. China Standard Time) to review the Company,s financial ...
... Perrigo Company (Nasdaq: PRGO ; TASE) today ... 2012. (Logo:   http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) ... "We are very pleased with our record fiscal third ... made possible by the continued operational excellence of the ...
Cached Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results 2Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 2Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 3Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 4Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 5Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 6Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 7Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 8Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 9Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 10Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 11Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 12Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 13Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 14Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 15Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 16Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 17Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance 18
... a rapid, real-time thermal cycler used for ... automating much of the testing process, and ... is the fastest, easiest to use, and ... The SmartCycler delivers highly accurate and consistent ...
... is a rapid, real-time thermal cycler used ... By automating much of the testing process, ... it is the fastest, easiest to use, ... market. The SmartCycler delivers highly accurate and ...
... The SmartCycler System is a rapid, ... from prepared biological samples. By automating much ... reaction site individually programmable, it is the ... system now on the market. The SmartCycler ...
... is a rapid, real-time thermal cycler used ... By automating much of the testing process, ... it is the fastest, easiest to use, ... market. The SmartCycler delivers highly accurate and ...
Medicine Products: